Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Dermatology and Therapy|July 18, 2025
Well-Being in Psoriasis: Weighting its Components Using Best-worst Scaling MethodologyEsteban Daudén, Isabel Belinchón, Elena Colominas-González, et al.
Experimental Dermatology|October 15, 2020
Genome-wide association analysis of psoriasis patients treated with anti-TNF drugsMaría C Ovejero-Benito, Ester Muñoz-Aceituno, David Sabador, et al.
Frontiers in Immunology|October 9, 2023
A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasisPablo Coto-Segura, Cristina Segú-Vergés, Antonio Martorell, et al.
Molecular and Cellular Endocrinology|March 13, 2016
KCNQ1 gene variants in the risk for type 2 diabetes and impaired renal function in the Spanish Renastur cohortCristina Riobello, Juan Gómez, Helena Gil-Peña, et al.
Rheumatology International|April 9, 2017
Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from SpainJuan Carlos Torre-Alonso, Loreto Carmona, Mireia Moreno, et al.
Plos One|July 15, 2016
A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing SpondylitisJose Ramón Vidal-Castiñeira, Antonio López-Vázquez, Roberto Diaz-Peña, et al.
Seminars in Arthritis and Rheumatism|May 9, 2018
High rates of tuberculin skin test positivity due to methotrexate therapy: False positive results?Miguel Arias-Guillén, Marta M Sánchez Menéndez, Mercedes Alperi, et al.
Experimental Dermatology|January 8, 2016
Identification of two rare and novel large deletions in ITGB4 gene causing epidermolysis bullosa with pyloric atresiaÁngeles Mencía, Marta García, Eva García, et al.
Dermatologic Therapy|June 22, 2022
Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice settingPablo Chicharro, Mar Llamas-Velasco, Susana Armesto, et al.
Dermatology and Therapy|September 25, 2021
Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in SpainEsteban Daudén, Glauber Pacelli Gomes de Lima, Susana Armesto, et al.
Pageof 7